Dr. Tsai graduated from the Northwestern University Feinberg School of Medicine in 2001. He works in Tucson, AZ and 1 other location and specializes in Gastroenterology. Dr. Tsai is affiliated with Carondelet Saint Josephs Hospital and Cornerstone Hospital Of Southeast Arizona.
Dr. Tsai graduated from the George Washington University School of Medicine and Health Science in 1998. He works in Centreville, VA and 1 other location and specializes in Pediatrics and Adolescent Medicine. Dr. Tsai is affiliated with Inova Fair Oaks Hospital.
Dr. Tsai graduated from the Ohio State University College of Medicine in 1987. He works in Massillon, OH and specializes in Cardiovascular Disease. Dr. Tsai is affiliated with Mercy Medical Center.
Kaiser Permanente Medical GroupKaiser Permanente Anesthesiology 9300 Imperial Hwy, Downey, CA 90242 (562)4613000 (phone), (562)6579953 (fax)
Education:
Medical School Albert Einstein College of Medicine at Yeshiva University Graduated: 1997
Languages:
English
Description:
Dr. Tsai graduated from the Albert Einstein College of Medicine at Yeshiva University in 1997. He works in Downey, CA and specializes in Pediatric Anesthesiology.
Physics Teacher at Townsend Harris High School, Computer/Network Administrator and Technology Coordinator at Townsend Harris High School
Location:
Greater New York City Area
Industry:
Education Management
Work:
Townsend Harris High School since Oct 2001
Physics Teacher
Townsend Harris High School since 2001
Computer/Network Administrator and Technology Coordinator
RTS Wireless/Aether Systems Aug 1998 - Jun 2001
Programmer/DBA
Reuters Feb 1992 - Aug 1998
Project Lead
GE Aerospace Aug 1990 - Feb 1992
Programmer
Education:
Stevens Institute of Technology 1988 - 1989
MS, Computer Science
Columbia University in the City of New York 1982 - 1986
BS, EE
nchise and Global Head of Medical Affairs for the Pharmaceuticals business unit. Dr. Aradhye will report to Vas Narasimhan and join the ECN. With the changes in organizational structure and operating model, John Tsai, M.D., has decided to pursue opportunities outside Novartis effective May 15th, 2022.
Date: Apr 04, 2022
Category: Business
Source: Google
Novartis to test hydroxychloroquine for coronavirus
We recognise the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with COVID-19 disease, said John Tsai, head of Global Drug Development and chief medical officer at Novartis. We mobilised quickly to address this question in a randomise